MARKET

BIIB

BIIB

Biogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

336.64
-4.40
-1.29%
After Hours: 336.12 -0.52 -0.16% 16:15 02/20 EST
OPEN
342.18
PREV CLOSE
341.04
HIGH
343.00
LOW
332.50
VOLUME
1.48M
TURNOVER
--
52 WEEK HIGH
374.99
52 WEEK LOW
215.78
MARKET CAP
58.60B
P/E (TTM)
10.70
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BIIB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 32 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BIIB News

  • Biogen Stock Recently Broke Out On A Patent Win Should You Buy Shares?
  • Investor's Business Daily.7h ago
  • Zacks Market Edge Highlights: Tesla, Micron, Biogen, GameStop and Maxar Technologies
  • Zacks.7h ago
  • Warren Buffett's Big Biotech Bet Is 1 of His Riskiest Wagers Ever
  • MotleyFool.com.1d ago
  • Healthcare And Biotechnology Dashboard - Update
  • Seeking Alpha - Article.1d ago

More

Industry

Pharmaceuticals
-0.53%
Pharmaceuticals & Medical Research
-0.42%

Hot Stocks

Name
Price
%Change

About BIIB

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.
More

Webull offers Biogen Inc (BIIB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.